AstraZeneca’s rare disease unit Alexion has penned a $825 million deal for AAV capsids from existing partner JCR Pharmaceuticals.

“I am very pleased to announce the signing of this license agreement for our proprietary AAV capsid platform, JUST-AAV,” said Shin Ashida, Chairman, President and CEO of JCR Pharmaceuticals.

The Edmonton Oilers have re-signed pending RFA defenseman Evan Bouchard to a four-year, $10.5 million AAV contract, league sources told The Athletic ’s Chris Johnston. Bouchard, 25, led the ...

Adeno-associated virus (AAV)–mediated gene therapy has emerged as a promising treatment for hemophilia B. Data on safety and durability from 13 years of follow-up in a cohort of patients who had ...

Many have speculated that the Ducks will be a major player in the Mitch Marner sweepstakes. The All-Star winger is nearly guaranteed to hit the open market on July 1, and Anaheim has the third ...

A new study will evaluate the safety and efficacy of universal allogeneic anti-CD19/BCMA CAR T-cells in relapsed or refractory autoimmune diseases including antineutrophil cytoplasmic antibody ...

TSP-1 reduced C3 and C5 cleavage and formation of the membrane attack complex, attenuating complement-mediated injury in AAV models.

Engineered AAV vectors with dual tumor-specific promoters for safer and more effective cancer therapy.. If you have the appropriate software installed, you can download article citation data to the ...

'The Pioneer Woman' star Ree Drummond celebrated her daughter Paige's wedding over the weekend, and she shared lots of photos and video of the stunning ceremony.

The AAV-Ep+ capsid variant was identified through a massively parallelled and unbiased screen of a large-diversity AAV variant library administered to NHPs.

Conquering the Complexities of AAV Manufacturing: Advances in Efficiency, Scalability, Compliance CDMOs/CROs are making progress in removing traditional production bottlenecks to AAV-based gene ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their research efforts around the adeno-associated virus (AAV) vectors used ...